Star Health and Allied Insurance Company Ltd.

NSE: STARHEALTH | BSE: 543412

Mid-range Performer

Download real time

435.40 0.50 (0.11%)

32.70% Fall from 52W High

287.7K NSE+BSE Volume

NSE 11 Aug, 2025 3:14 PM (IST)

25,587.6

Market Cap

Low in industry

0.6

Beta 1Year

Very Low volatility

Star Health and Allied Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for STARHEALTH, BSE:543412 Star Health and Allied Insurance Company Ltd.

Search Inside the pdf :

Star Health and Allied Insurance Company Ltd.

30 Jul 2025

435.40

0.11%

In-line underwriting performance

Buy: Star Health and Allied Ins...

Target

Motilal Oswal

Star Health’s (STARHEAL) net earned premium rose 12% YoY to INR39.4b (in line) during 1QFY26. Claims ratio at 69.5% (in line) grew 190bp YoY, driven by a 15% YoY increase in net claims incurred to INR27.4b (in line).

Star Health and Allied Insurance Company Ltd. has gained 21.05% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

14 May 2025

435.40

0.11%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Target

Geojit BNP Paribas

The company is currently facing challenges due to the new accounting standards and a surge in claim frequency and severity, which are affecting its profitability. However, recent price adjustments are expected to mitigate the impact of rising medical costs and hospitalisation trends, potentially leading to a gradual decline in the claims ratio over the next few quarters. A potential reduction in expense ratios and stable commission ratios are expected as the company grows. Additionally, the company is adopting a targeted approach by focusing on specific market segments...

Star Health and Allied Insurance Company Ltd. has gained 21.05% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

13 Feb 2025

435.40

0.11%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Recommendation Target

Geojit BNP Paribas

Star Health and Allied Insurance Company Ltd.'s price crossed above 50Day SMA today

Star Health and Allied Insurance Company Ltd.

30 Jan 2025

435.40

0.11%

Arduous journey toward gradual recovery in claims ratio

Buy: Star Health and Allied Ins...

Recommendation

Emkay

Star Health reported weak performance for Q3FY25, with GWP growth at 5.3% (at a 1.8% miss) impacted by implementation of the 1/n regulation and Combined Ratio at 103.3% vs our estimate of 100.5% driven by higher Claims and Expense Ratio (affected by 1/n premium accounting of long-term policies).

Star Health and Alli.. has an average target of 516.50 from 4 brokers.

Star Health and Allied Insurance Company Ltd.

11 Nov 2024, 12:00AM

435.40

0.11%

Star Health Allied Ins. Co.

Buy: Star Health and Allied Ins...

Target

ICICI Direct

Star Health and Allied Insurance Company Ltd. has gained 21.05% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

04 Sep 2024

435.40

0.11%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Buy: Star Health and Allied Ins...

Target

Geojit BNP Paribas

Star Health and Allied Insurance Company Ltd. is trading below its 50 day SMA of 437.7

Star Health and Allied Insurance Company Ltd.

26 Aug 2024

435.40

0.11%

Star Health Allied Ins. Co.

Buy: Star Health and Allied Ins...

Target

ICICI Direct

Star Health and Allied Insurance Company Ltd. is trading above its 200 day SMA of 433.4

Star Health and Allied Insurance Company Ltd.

04 Aug 2024

435.40

0.11%

FY25 may accrue benefits of price hikes, new channels and better investment performance

Buy: Star Health and Allied Ins...

ICICI Securities Limited

Star Health and Allied Insurance’s (Star) Q1FY25 profit of INR 3.2bn was in line with our estimate driven by better than-expected investment performance, offsetting the impact of higher-than-expected claims ratio.

Star Health and Allied Insurance Company Ltd.'s price crossed above 50Day SMA today

Star Health and Allied Insurance Company Ltd.

28 Jun 2024

435.40

0.11%

Earnings outlook gets lifted with COR improvement outlook; compliments strong industry position

Buy: Star Health and Allied Ins...

Target

ICICI Securities Limited

We attended Star Health’s (Star) ‘Investor and Analyst Day’ on 27 Jun’24 in Chennai. Star is building well on its vantage in the retail segment via a well-concerted strategy encompassing distribution, product innovation, superior claims processing and enhanced underwriting.

Star Health and Allied Insurance Company Ltd. has gained 21.05% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

28 Jun 2024

435.40

0.11%

Focusing on profitable growth

Buy: Star Health and Allied Ins...

Motilal Oswal

Overall, the company aims to double its GWP and triple its PAT by FY28. We estimate STARHEAL to deliver FY26E combined ratio/RoE of 94.9%/17.0%. We reiterate our BUY rating with a TP of INR730.

Star Health and Allied Insurance Company Ltd.'s price crossed above 50Day SMA today

VOTE: Is Star Health and Allied Insurance Company Ltd. worth buying?

147 Votes:

Buy 85.71%

Sell 9.52%

Hold 4.76%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf